iShares
The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Pharmaceuticals Index.
Top Holdings*as of 2/7/2012
View all holdings
Name % of Fund
JOHNSON & JOHNSON 9.33%
PFIZER INC 9.03%
MERCK & CO. INC. 8.21%
ABBOTT LABORATORIES 6.93%
BRISTOL-MYERS SQUIBB CO 5.56%
ELI LILLY & CO 4.97%
ALLERGAN INC 4.42%
MYLAN INC 3.28%
FOREST LABORATORIES INC 2.92%
HOSPIRA INC 2.87%
Total57.52%
Sector Breakdownas of 2/7/2012*
View all holdings
Sector % of Fund  
 
Pharmaceuticals
99.78%
 
S-T Securities
0.04%
 
Other/Undefined
0.18%
 
 
 
*Holdings are subject to change
Avg. Annualized Total Returns (NAV)qtr. as of 12/31/2011
View all performance
1 Year
3 Years
5 Years
10 Years
 Since Inception
IHE 21.20% 21.20% 9.08% -- 9.32%
Index Index 21.81% 21.78% 9.63% -- 9.87%
Yield as of 1/31/2012
View all distributions
Description %
30-Day SEC Yield 30-Day SEC Yield 1.33%
12-Month Yield 12-Month Yield
as of 1/31/2012 		1.16%
Fundamentals & Risk as of 1/31/2012
Description Value
Price to Earnings Ratio Price to Earnings Ratio21.19
Price to Book Ratio Price to Book Ratio6.05
Beta Beta (vs S&P 500)
vs S&P 500 		0.60
Standard Deviation (3 year) Standard Deviation 16.62%
Profile as of 2/8/2012
Description Value
Total Net Assets$383,423,686
Expense Ratio0.47%
Shares Outstanding4,850,000
Number of Holdings
as of 2/7/2012		 39
Inception Date5/1/2006
Related IndexDJSPHMT
Net Asset Value
as of 2/8/2012		 $79.06
  • $-0.29
  • -0.36%

Price

as of 2/7/2012 		$79.37
  • $-0.15
  • -0.19%
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. This information must be accompanied by standardized returns. For standardized returns and performance data current to the most recent month end, click the "Performance" tab above.
Fees & Expenses
Expense Type %
Management Fees 0.47%
+
 Acquired Fees & Expenses ‡ 0.00%
=
 Total Annual Fund Operating Expenses 0.47%
Trading Information
Identifier Type Symbol
TickerIHE
Related IndexDJSPHMT
NAVIHE.NV
Underlying Trading ValueIHE.IV
Shares OutstandingIHE.SO
Estimated CashIHE.EU
Total CashIHE.TC
CUSIP464288836

Carefully consider the iShares Funds' investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the Funds' prospectuses, which may be obtained by calling 1-800-iShares (1-800-474-2737), or by viewing or downloading a prospectus. Read the prospectus carefully before investing.

Investing involves risk, including possible loss of principal.

‡ “Acquired Fund Fees and Expenses” reflect the Fund's pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. Acquired Fund Fees and Expenses are reflected in the prices of the acquired funds and thus included in the total returns of the Fund.

The iShares Funds ("Funds") are distributed by SEI Investments Distribution Co. ("SEI"). BlackRock Fund Advisors ("BFA") serves as the investment advisor to the Funds. BFA is a subsidiary of BlackRock Institutional Trust Company, N.A., neither of which is affiliated with SEI.

Narrowly focused investments typically exhibit higher volatility.

Pharmaceutical and medical device companies may be subject to severe competition and product obsolescence. These companies may be adversely affected by loss of patent protection, subject to extensive product liability litigation and thinly traded. New products are subject to government approvals, regulation and reimbursement rates.

Index returns are for illustrative purposes only and do not represent actual iShares performance. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.

"Dow Jones U.S. Select Pharmaceuticals Index" is a product of Dow Jones Indexes, the marketing name and a licensed trademark of CME Group Index Services LLC ("CME Indexes") and has been licensed for use. "Dow Jones®", "Dow Jones U.S. Select Pharmaceuticals Index" and "Dow Jones Indexes" are servicemarks of Dow Jones Trademark Holdings, LLC ("Dow Jones"), have been licensed to CME Indexes and have sublicensed for use for certain purposes by BlackRock Institutional Trust Company, N.A. iShares Funds based on the Dow Jones Indexes are not sponsored, endorsed, issued, sold or promoted by Dow Jones, CME Indexes or their respective affiliates and Dow Jones, CME Indexes and their respective affiliates make no representation regarding the advisability of investing in such product(s). Neither SEI, nor BlackRock Institutional Trust Company, N.A., nor any of their affiliates, are affiliated with the companies listed above. Index data source: Dow Jones Indexes.

Shares of iShares Funds are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.

Certain sectors and markets perform exceptionally well based on current market conditions and iShares funds can benefit from that performance. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such results will be repeated.

© 2000-2012 BlackRock Institutional Trust Company, N.A. All rights reserved. iShares® is a registered trademark of BlackRock Institutional Trust Company, N.A. BlackRock® is a registered trademark of BlackRock, Inc. All other trademarks, servicemarks or registered trademarks are the property of their respective owners.

© 2000-2012